REGENXBIO Reports Positive Biomarker Data from the AFFINITY DUCHENNE ®Trial of RGX-202 Gene Therapy
“RGX-202 is the only next generation gene therapy for Duchenne [...]
“RGX-202 is the only next generation gene therapy for Duchenne [...]
Published online March 19 in the journal Nature, the study [...]
“There has been far too little effort to raise awareness [...]
Charm AI Scribe captures the natural dialogue between the patient [...]
Carsten Schroeder, President and CEO of Terumo Neuro, commented on [...]
This achievement places RenyMed in the top 5% of all [...]
Michael Andersen brings more than 20 years of commercial leadership [...]
“These improvements underscore our dedication to supporting physicians in making [...]
SubtleHD sets a new benchmark in image quality and speed [...]
With the right mix of planning, monitoring and data management, [...]